Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.3K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

3.7K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
3.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxysafflor Yellow A Attenuates Hydrogen Peroxide-Induced Oxidative Damage on Human Umbilical Vein Endothelial Cells.

Evidence-based complementary and alternative medicine : eCAM·2020
Same author

2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside modulated human umbilical vein endothelial cells injury under oxidative stress.

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology·2020
Same author

Evaluation of the impact of suspended particles on the UV absorbance at 254 nm (UV<sub>254</sub>) measurements using a submersible UV-Vis spectrophotometer.

Environmental science and pollution research international·2020
Same author

Ferulic acid (FA) protects human retinal pigment epithelial cells from H<sub>2</sub> O<sub>2</sub> -induced oxidative injuries.

Journal of cellular and molecular medicine·2020
Same author

SIRT1 Is the Target Gene for 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside Alleviating the HUVEC Senescence.

Frontiers in pharmacology·2020
Same author

Fast and effective biomedical named entity recognition using temporal convolutional network with conditional random field.

Mathematical biosciences and engineering : MBE·2020
Same journal

circ2DGNN: circRNA-Disease Association Prediction via Transformer-Based Graph Neural Network.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Hierarchical Hypergraph Learning in Association- Weighted Heterogeneous Network for miRNA- Disease Association Identification.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Discriminative Domain Adaption Network for Simultaneously Removing Batch Effects and Annotating Cell Types in Single-Cell RNA-Seq.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

MLW-BFECF: A Multi-Weighted Dynamic Cascade Forest Based on Bilinear Feature Extraction for Predicting the Stage of Kidney Renal Clear Cell Carcinoma on Multi-Modal Gene Data.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

An End-to-End Knowledge Graph Fused Graph Neural Network for Accurate Protein-Protein Interactions Prediction.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Generative Biomedical Event Extraction With Constrained Decoding Strategy.

IEEE/ACM transactions on computational biology and bioinformatics·2024
See all related articles

Related Experiment Video

Updated: Oct 1, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.0K

Predicting Drug-Target Interaction Via Self-Supervised Learning.

Jiatao Chen, Liang Zhang, Ke Cheng

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |March 1, 2022
    PubMed
    Summary
    This summary is machine-generated.

    SupDTI enhances drug-target interaction (DTI) prediction using self-supervised learning (SSL) on heterogeneous networks. This framework improves prediction accuracy by leveraging graph convolutions and unified self-supervised strategies.

    More Related Videos

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.8K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.3K

    Related Experiment Videos

    Last Updated: Oct 1, 2025

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    3.0K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.8K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.3K

    Area of Science:

    • Computational drug discovery
    • Graph representation learning
    • Bioinformatics

    Background:

    • Graph representation learning offers new avenues for drug-target interaction (DTI) prediction.
    • Current DTI prediction methods face challenges with manual label dependency and vulnerability to attacks.
    • Self-supervised learning (SSL) effectively utilizes input data for supervision, offering a promising alternative.

    Purpose of the Study:

    • To propose SupDTI, a novel SSL-enhanced framework for DTI prediction.
    • To leverage heterogeneous networks for comprehensive drug and protein information integration.
    • To improve the accuracy and robustness of computational DTI prediction.

    Main Methods:

    • Developed SupDTI, an end-to-end framework integrating localized and globalized graph convolutions.
    • Employed a variational autoencoder to constrain node representations with desired statistical properties.
    • Implemented a unified SSL strategy combining contrastive and generative learning modules for enhanced node representations.

    Main Results:

    • SupDTI effectively captures both local and global node information within heterogeneous networks.
    • The unified SSL strategy significantly enhances the quality of node representations.
    • Experimental results demonstrate superior DTI prediction performance compared to state-of-the-art methods.

    Conclusions:

    • SupDTI offers a robust and effective approach to computational DTI prediction.
    • SSL integration overcomes limitations of manual labels and enhances model resilience.
    • The proposed framework advances the field of computational drug discovery and personalized medicine.